Method for improving erythromycin production by transforming Saccharopolyspora erythromycetes sace_3980 gene
A technology of Saccharopolyspora erythromycin and erythromycin, which is applied in the field of genetic engineering, can solve the problems such as the lack of research on the regulation genes of the TetR family of secondary metabolism of Saccharopolyspora erythromycin, and the unclear elucidation of the precise mechanism of erythromycin.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Publication Date
- 2021-01-01
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of genetic engineering, in particular to a method for improving the yield of erythromycin by modifying the gene of Saccharopolyspora erythromycetes SACE_3980. Background technique
[0002] Erythromycin is produced by the secondary metabolism of Saccharopolyspora erythromycetes and is a typical polyketide antibiotic. Its components include erythromycin A (Er-A), erythromycin B (Er-B), erythromycin C (Er-C), erythromycin D (Er-D), erythromycin E (Er-E) and erythromycin F (Er-F), etc. This type of antibiotic has a broad-spectrum antibacterial effect, and its antibacterial spectrum is similar to that of penicillin, and has a strong inhibitory effect on Gram-positive bacteria. Among the various components of erythromycin, erythromycin A is widely used clinically, and its antibacterial activity is the highest, while chemical derivatives of erythromycin series (clarithromycin, azithromycin, roxithromycin, telithro...
Examples
Embodiment 1
[0030] 1.1 Strains, plasmids and growth conditions